Article Key Point: What should retirement plan committees ask about their advisor’s ownership?
Retirement plan committees should understand who owns their consultant, how the firm and its affiliates make money, whether they earn revenue from plan participants, whether employees are incentivized to cross-sell services, and how participant data can be used. These questions can help fiduciaries identify and evaluate potential conflicts of interest.
Full Article
I never owned a pet until 2017, when we brought home our first cat, Hugh. Hugh was eventually joined by our first dog in 2020, Theo. In my hometown of Portland, everyone has a pet, and while I was aware that pets need food and medical care, the cost of being a pet owner caught me by surprise.
If you’ve taken a dog or cat to the vet lately, you know the moment at the front desk: the bill is much higher than you expected. My kids and my dog have allergies. A year’s worth of Allertec from the pharmacy for my kids ($24) / a year’s worth of Apoquel for Theo ($500 - $1,800).
Over the past decade, veterinary prices have risen by roughly 55–60%, compared with about 35% for prices overall.
One of the things that has changed in the last decade is who owns the clinic. What happened to pet owners holds a lesson for retirement plan committees, because the same ownership model is now reshaping the firms that advise them.
What happened in veterinary care
In 2010, about one in 10 U.S. vet practices was corporately owned. Today, corporate groups own roughly a quarter of primary care practices and about three-quarters of specialty and emergency hospitals. Together, they take in about half of all veterinary revenue, and most are backed by private equity.
Prices climbed over the same stretch. Since 2019, veterinary services have risen 55.5% through March 2026, the fastest of any pet-related category and ahead of gasoline and restaurant meals.
Correlation isn’t causation. Pandemic demand, general inflation, and higher wages for vets and technicians all played a part. But the clearest test comes from the UK, where the competition regulator spent more than two years studying the market. It found:
- Large corporate groups grew from about 10% of practices in 2013 to 60%.
- Vet prices rose 63% from 2016 to 2023, against 32% general inflation.
- Pet owners paid roughly 17–18% more at large groups than at independent practices.
- For at least three large groups, prices rose faster at practices they acquired than at practices that stayed independent.
That last finding is the closest thing to proof: the same clinic, under new ownership, raised prices faster than its independent neighbors.
The real business model is the ecosystem
Raising the price of an exam is the obvious lever. The bigger one is the one that gets sold around the exam.
The largest owners of vet clinics own far more than clinics. One owns general practices, specialty hospitals, the diagnostic labs that process samples, and a leading line of prescription pet food. Another pair one of the largest clinic networks with a fast-growing pet insurance platform, and describes its goal as a pet health ecosystem covering an animal’s entire life. Owning the clinic, the lab, the food, and the insurance doesn’t prove anyone is being steered. It does build a business where the exam room is the storefront.
The UK regulator found the steering is real. Online pharmacies typically sold common medicines for 50–60% less than the practice did, yet fewer than six in ten pet owners knew they could ask for a written prescription and buy elsewhere. The remedies go straight to the mechanism. Practices must disclose who owns them, publish prices, cap prescription fees, and tell owners when medicines may be cheaper elsewhere. They also need written policies so vets can give impartial advice.
In the U.S., vets at corporate practices report more pressure than their independent peers to generate revenue and see more patients per shift. The pattern is simple: the most trusted person in the transaction becomes the distribution channel.
The same playbook in retirement plan consulting
Retirement plan consulting has followed a similar arc. Over the past decade, private equity-backed firms have rolled up advisory practices at a rapid pace. Some may even keep a local name and the familiar faces, so a committee may not notice that its consultant now answers to a new owner.
The price story looks different here. Consulting fees charged to plan sponsors haven’t climbed the way vet bills have; benchmarking and competition have mostly pushed them down. That doesn’t mean the economics have gotten better for plans. It means the money has moved.
Much like maintaining reasonably priced pet exams, the growth engine for a consolidated advisory firm usually isn’t the committee’s fee. It’s the participants’: wealth management, IRA rollovers at separation or retirement, managed accounts, and other products the firm or its affiliates sell. The consultant’s access to the plan and the committee’s implied endorsement are the storefront. It’s the exam room.
Where the analogy breaks, and why that’s worse
In veterinary care, the pet owner is both the decision-maker and the buyer. When the clinic recommends the prescription diet or the wellness plan, the owner hears the pitch and decides.
In a retirement plan, the committee is the pet owner. It hires the consultant, oversees the relationship, and carries the fiduciary duty. The participants are the pets. But unlike pets, participants can be sold to directly, and the sale can occur without the committee ever seeing it. Imagine your vet calling your dog directly to offer a supplement plan or a new treat subscription.
That is the core risk. The committee approves a consulting fee that looks reasonable, while a second, often larger revenue stream runs from its participants to the consultant’s parent company. Participants never chose this advisor. They trust it because the committee did.
Questions every committee should ask
A regulator had to force vet clinics to answer these questions. Committees don’t need to wait for one.
- Who owns our consultant, and has that changed? Ask for the full ownership chain, including any private equity sponsor, and when that sponsor expects to sell.
- What does the firm, or any affiliate, earn from our participants? Rollovers, wealth management, managed accounts, and insurance. Ask for dollars, not just disclosure language.
- Is anyone paid or evaluated on cross-selling? Find out whether advisors or service teams are measured on participant assets gathered.
- What can the firm do with our participant data? Check whether your contract restricts its use for marketing.
- Would the advice change if the firm earned nothing from our participants? If the honest answer is “maybe,” the committee has a conflict to manage.
Independence is a structure, not a slogan
Pet owners learned the hard way that the friendly local clinic may answer to a balance sheet they can’t see. Plan committees can learn it the easy way.
A consultant’s value comes from advice that isn’t shaped by what else the firm wants to sell. Whether that’s true isn’t a matter of marketing. It depends on who owns the firm and how it gets paid. Ask, and get the answers in writing.
Sources
- UK Competition and Markets Authority: Veterinary services final decision report
- Global Pet Industry: CMA provisional decision findings
- Agilio: Summary of the CMA final decision
- Pharmacy2U: CMA final reforms on medicines and prescriptions
- Frontiers in Veterinary Science: Corporate ownership shares (2025)
- Asheville Watchdog: Corporate ownership in 2010
- Pet Food Industry: Veterinary inflation since 2019
- Veterinary Practice News: Ten-year vet price increase vs. CPI
- Veterinary Vertex: JAVMA study of corporate vs. private practice vets
- Insurance Journal: Pet insurance platform paired with a clinic network
- Feedstuffs: Clinic, lab and pet food ownership combined
Multnomah Group is a registered investment adviser registered with the Securities and Exchange Commission. Any information contained herein or on Multnomah Group’s website is provided for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and, unless otherwise stated, are not guaranteed. Multnomah Group does not provide legal or tax advice.

